Brokerages Set Addus HomeCare Co. (NASDAQ:ADUS) Price Target at $116.25

Addus HomeCare Co. (NASDAQ:ADUS) has earned a consensus rating of “Moderate Buy” from the nine research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell rating and eight have assigned a buy rating to the company. The average 12-month price target among analysts that have covered the stock in the last year is $116.25.

Several equities analysts have issued reports on ADUS shares. Stephens lifted their price target on shares of Addus HomeCare from $120.00 to $128.00 and gave the stock an “overweight” rating in a report on Friday, May 31st. Barclays downgraded shares of Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 price objective for the company. in a research note on Tuesday, April 23rd. Macquarie initiated coverage on shares of Addus HomeCare in a research note on Friday, June 28th. They set an “outperform” rating and a $136.00 price objective for the company. Oppenheimer lifted their price objective on shares of Addus HomeCare from $118.00 to $130.00 and gave the stock an “outperform” rating in a research note on Friday, June 7th. Finally, TD Cowen lifted their price objective on shares of Addus HomeCare from $119.00 to $128.00 and gave the stock a “buy” rating in a research note on Tuesday, June 18th.

Addus HomeCare Price Performance

NASDAQ ADUS opened at $122.83 on Wednesday. The firm’s fifty day simple moving average is $115.02 and its two-hundred day simple moving average is $101.95. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. Addus HomeCare has a 12-month low of $78.35 and a 12-month high of $123.85. The firm has a market capitalization of $2.22 billion, a P/E ratio of 30.48, a P/E/G ratio of 2.33 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, May 6th. The company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.97 by $0.24. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. The business had revenue of $280.70 million for the quarter, compared to analyst estimates of $279.49 million. During the same period in the previous year, the company earned $0.84 earnings per share. The business’s revenue for the quarter was up 11.6% on a year-over-year basis. Analysts forecast that Addus HomeCare will post 4.36 EPS for the current fiscal year.

Insider Activity at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $116.13, for a total transaction of $25,200.21. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,186,500.21. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 4.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Principal Securities Inc. acquired a new position in shares of Addus HomeCare in the fourth quarter worth about $26,000. GAMMA Investing LLC acquired a new position in shares of Addus HomeCare in the fourth quarter worth about $34,000. EntryPoint Capital LLC acquired a new position in shares of Addus HomeCare in the first quarter worth about $44,000. Assetmark Inc. raised its position in shares of Addus HomeCare by 33.3% in the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock worth $165,000 after acquiring an additional 443 shares during the period. Finally, Envestnet Portfolio Solutions Inc. acquired a new position in shares of Addus HomeCare in the fourth quarter worth about $214,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.